Every year from November 18 to 24, the Centers for Disease Control and Prevention (CDC) and hundreds of partner organizations observe U.S. Antibiotic Awareness Week (USAAW), a reminder that antibiotics are lifesaving tools that lose their effectiveness when they are used when they are not needed [1]. In workers’ compensation, that message has a very practical edge. Lacerations, puncture wounds, and contaminated injuries present a daily question for occupational medicine providers: when does infection prevention justify an antibiotic, and when does it become unnecessary prescribing? As antibiotic resistance continues to grow, workers’ compensation stakeholders have both a public health responsibility and a claim-level reason to get this balance right.
Why This Year’s Observance Matters
The stakes are rising. In October 2026, CDC released an updated Antimicrobial Resistance Threats Report estimating that more than 9.3 million drug-resistant infections occur in the United States each year and that more than 39,000 people die as a result. When Clostridioides difficile (C. diff), an infection closely tied to antibiotic use, is included, the totals reach 9.7 million infections and 50,800 deaths [2].
CDC also updated its Core Elements of Outpatient Antibiotic Stewardship in 2026, the first revision of the original 2016 guidance, placing new emphasis on how health systems can improve prescribing across their networks [3]. Because injured workers are so often treated in outpatient, urgent care, and occupational health settings, both developments are directly relevant to workers’ compensation.
The Scope of the Problem
According to the Bureau of Labor Statistics (BLS), cuts, lacerations, and punctures accounted for 179,080 private-industry cases involving days away from work across 2023 and 2024, nearly one in ten of all such cases [4]. Manufacturing accounted for 29,100 of them, but workplace wounds occur across nearly every industry, from construction sites and warehouses to restaurants and healthcare facilities. These counts also capture only injuries serious enough to keep a worker off the job; many more are treated and returned to work the same day.
Many injured workers receive initial treatment at urgent care centers or occupational health clinics, where prescribing practices vary. In a national analysis of 2014 commercial claims data, urgent care centers prescribed antibiotics in 45.7% of visits for respiratory diagnoses that do not require them, the highest rate among the outpatient settings studied [5]. More recent work is encouraging: a 2025 quality improvement study across 49 urgent care centers found that inappropriate prescribing fell by 48% for bronchitis and by 33% for viral upper respiratory infections among clinicians who were actively engaged in a stewardship intervention [6]. Data specific to occupational wound care remain limited, so these respiratory findings are best read as a signal about prescribing culture in these settings rather than a direct measure of wound care practice.
Understanding When Antibiotics Are Actually Needed
Not every workplace wound needs an antibiotic, even when it looks concerning. A widely cited review in American Family Physician is direct on this point: “Prophylactic systemic antibiotics are not necessary for healthy patients with clean, noninfected, nonbite wounds” [7]. The deciding factors are the characteristics of the wound and the risk profile of the patient.
Clean, Simple Lacerations
For uncomplicated lacerations in healthy patients, thorough irrigation, removal of devitalized tissue, and appropriate closure are the foundation of infection prevention [7]. For simple hand lacerations specifically, a systematic review found no clear benefit from prophylactic antibiotics; however, the authors noted that the available trials were limited in size and quality and called for a definitive clinical trial [8].
When Antibiotics May Be Warranted
Clinical guidance supports considering antibiotic prophylaxis for injuries with a higher risk of infection [7, 9]:
- Wounds with significant tissue destruction or devitalized tissue
- Heavy contamination, such as soil, farm, or sewage exposure
- Bite wounds, particularly human bites to the hand and moderate to severe bites of the hand or face
- Deep puncture wounds, especially to the hand or foot
- Open fractures
- Patients with conditions that increase infection risk, such as diabetes or immunosuppression
Even in higher-risk scenarios, duration matters. Evidence on the optimal length of prophylaxis for contaminated soft tissue wounds is limited. One small trial of heavily contaminated lacerations found that a 2-day course of cephalexin performed as well as a 5-day course, with infection rates of 8.6% and 7.1%, a difference that was not statistically significant [10]. For open fractures, trauma surgery consensus guidance similarly favors short courses of prophylaxis, generally limited to about 24 hours, with longer courses reserved for heavily contaminated wounds [9].
The Hidden Costs of Overuse
Inappropriate prescribing carries consequences that reach well beyond the cost of the prescription.
Resistance Development. Every antibiotic course, appropriate or not, places selective pressure on bacteria. CDC’s 2026 estimate of more than 9.3 million drug-resistant infections each year is a clear reminder of why unnecessary prescriptions matter beyond the individual patient [2].
*C. diff* and Adverse Events. C. diff causes almost half a million infections in the United States each year, and patients are up to 10 times more likely to develop C. diff while taking an antibiotic and during the month that follows [11]. Prescribing patterns matter at the population level, too: a CDC-led analysis estimated that a 10% reduction in outpatient antibiotic prescribing was associated with a 17% decrease in community-associated C. diff infections [12].
Drug-Specific Risks for Injured Workers. Some antibiotic classes carry risks that are especially relevant in workers’ compensation. The U.S. Food and Drug Administration (FDA) has warned that fluoroquinolones can cause disabling and potentially permanent side effects involving tendons, muscles, joints, and nerves, including tendon rupture and peripheral neuropathy. For uncomplicated infections such as acute sinusitis and uncomplicated urinary tract infections, FDA advises reserving fluoroquinolones for patients who have no other treatment options [13]. For a worker recovering from a musculoskeletal injury, a tendon complication is not a minor side effect; it can extend disability and complicate the claim.
Claim Complications. Antibiotic-associated diarrhea, allergic reactions, and drug interactions can slow recovery and extend time away from work. Workers’ compensation pharmacy data adds another layer: because the claim captures only injury-related prescriptions, a worker’s other medications are often invisible to the claim file, which makes interaction screening more difficult.
The Workers’ Compensation Context
Several factors unique to occupational injury care influence antibiotic prescribing.
- 1. Pressure for Quick Return to Work. The urgency to prevent infection and support a fast return to work can drive defensive prescribing. The evidence, however, points to appropriate wound care, rather than reflexive antibiotic use, as the primary driver of infection outcomes for most injuries [7].
- 2. Limited Follow-Up. Injured workers may have less consistent follow-up than patients in primary care, which can create pressure to “cover” a potential infection with antibiotics. Proper initial wound management remains more important than prophylactic antibiotics for preventing infection in low-risk wounds.
- 3. Variable Treatment Settings. Injured workers receive care in employer-based occupational health clinics, urgent care centers, and emergency departments, each with its own prescribing culture. Since January 1, 2020, The Joint Commission has required accredited ambulatory health care organizations that routinely prescribe antimicrobials, including urgent care and occupational and worksite health settings, to maintain antimicrobial stewardship activities [14]. Not every clinic is Joint Commission accredited, however, so the maturity of stewardship programs still varies.
- 4. Documentation Challenges. Workers’ compensation claims depend on clear documentation of medical necessity. For simple, clean wounds, a general note such as “to prevent infection” gives claims professionals and reviewers little to evaluate; documenting the specific wound characteristics or patient risk factors that support prophylaxis makes the clinical rationale clear.
Building a Stewardship Approach
Effective antibiotic stewardship in workers’ compensation does not mean withholding necessary treatment. It means applying evidence-based criteria consistently. Key strategies include:
Provider Education. Ensure treating physicians understand current guidance on wound management and antibiotic prophylaxis. CDC’s updated Core Elements of Outpatient Antibiotic Stewardship offers a practical framework built around leadership commitment, accountability, expertise, action, tracking, reporting, and education [3].
Risk Stratification. Develop clear protocols that identify which wound characteristics and patient factors justify antibiotic use. Tier wounds by infection risk rather than applying blanket policies.
Duration Limits. When antibiotics are appropriate, aim for the shortest effective course. For most wound prophylaxis, extended courses add risk without clear evidence of added benefit [9, 10].
Audit and Feedback. Review antibiotic prescribing patterns in occupational injury claims, identify outliers, and share the data with prescribers. CDC identifies audit and feedback as a core stewardship action, and the urgent care study cited above suggests that interventions work best when clinicians are actively engaged [3, 6].
Culture Change. Address the perception that an antibiotic prescription demonstrates thoroughness or reduces liability. For most wounds, the evidence shows that appropriate wound care, not routine antibiotics, prevents infection and protects both the worker and the claim.
A Relationship-Focused Approach
At Preferred Medical, we recognize that antibiotic decisions in workers’ compensation require balancing several priorities: worker safety, evidence-based medicine, cost management, and public health. Our pharmacy team works with treating physicians to help ensure antibiotic use aligns with clinical need rather than habit.
This includes:
- Providing guidance on injury-specific antibiotic indications
- Flagging durations that exceed evidence-based recommendations
- Reviewing drug-specific risks, such as fluoroquinolone use in workers recovering from musculoskeletal injuries
- Supporting alternative wound care strategies when antibiotics are not indicated
- Helping providers talk with injured workers about when antibiotics are not needed
The Bottom Line
Workplace injuries require thoughtful infection prevention, but infection prevention does not automatically mean antibiotics. For most simple, clean wounds, proper irrigation, debridement, and closure are the foundation of protection. When antibiotics are indicated because of wound characteristics or patient risk factors, the evidence generally favors shorter courses over longer ones.
U.S. Antibiotic Awareness Week is a good moment to revisit these practices, but stewardship is a year-round commitment. As resistance continues to threaten the effectiveness of these medications, workers’ compensation stakeholders have an opportunity, and a responsibility, to lead. The injured worker benefits from evidence-based care. The claim benefits from fewer avoidable complications. And public health benefits from preserving antibiotics for when they truly matter.
References
- Centers for Disease Control and Prevention. (2025). U.S. Antibiotic Awareness Week (USAAW) toolkit. https://www.cdc.gov/antimicrobial-resistance/communication-resources/usaaw.html
- Centers for Disease Control and Prevention. (2026, October 25). About antimicrobial resistance. https://www.cdc.gov/antimicrobial-resistance/about/index.html
- Centers for Disease Control and Prevention. (2026). Core elements of outpatient antibiotic stewardship. https://www.cdc.gov/antibiotic-use/hcp/core-elements/outpatient-antibiotic-stewardship.html
- U.S. Bureau of Labor Statistics. (2026). Table R1. Number of nonfatal occupational injuries and illnesses involving days away from work, restricted activity, or job transfer (DART), days away from work (DAFW), and days of restricted work activity, or job transfer (DJTR) by industry and selected natures of injury or illness, private industry, 2023–2024 [Data set]. https://www.bls.gov/iif/nonfatal-injuries-and-illnesses-tables/case-and-demographic-characteristics-table-r1-2023-2024.xlsx
- Palms, D. L., Hicks, L. A., Bartoces, M., Hersh, A. L., Zetts, R., Hyun, D. Y., & Fleming-Dutra, K. E. (2018). Comparison of antibiotic prescribing in retail clinics, urgent care centers, emergency departments, and traditional ambulatory care settings in the United States. JAMA Internal Medicine, 178(9), 1267–1269. https://doi.org/10.1001/jamainternmed.2018.1632
- Park, D. E., Roberts, A. L., Hamdy, R. F., Balthrop, S., Dolan, P., & Liu, C. M. (2025). Evaluating an urgent care antibiotic stewardship intervention: A multi-network collaborative effort. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2024.213
- Worster, B., Zawora, M. Q., & Hsieh, C. (2015). Common questions about wound care. American Family Physician, 91(2), 86–92.
- Zehtabchi, S., Yadav, K., Brothers, E., Khan, F., & Singh, S. (2012). Prophylactic antibiotics for simple hand lacerations: Time for a clinical trial? Injury, 43(9), 1497–1501.
- Appelbaum, R. D., Farrell, M. S., Gelbard, R. B., Hoth, J. J., Jawa, R. S., Kirsch, J. M., Mandell, S., Nohra, E. A., Rinderknecht, T., Rowell, S., Cuschieri, J., & Stein, D. M. (2024). Antibiotic prophylaxis in injury: An American Association for the Surgery of Trauma Critical Care Committee clinical consensus document. Trauma Surgery & Acute Care Open, 9(1), Article e001304. https://doi.org/10.1136/tsaco-2023-001304
- Ghafouri, H. B., Bagheri-Behzad, B., Yasinzadeh, M. R., Modirian, E., Divsalar, D., & Farahmand, S. (2012). Prophylactic antibiotic therapy in contaminated traumatic wounds: Two days versus five days treatment. BioImpacts, 2(1), 33–37. https://doi.org/10.5681/bi.2012.004
- Centers for Disease Control and Prevention. (n.d.). C. diff (Clostridioides difficile) [Fact sheet]. https://www.cdc.gov/c-diff/media/pdfs/Cdiff-Factsheet-P.pdf
- Dantes, R., Mu, Y., Hicks, L. A., Cohen, J., Bamberg, W., Beldavs, Z. G., Dumyati, G., Farley, M. M., Holzbauer, S., Meek, J., Phipps, E., Wilson, L., Winston, L. G., McDonald, L. C., & Lessa, F. C. (2015). Association between outpatient antibiotic prescribing practices and community-associated Clostridium difficile infection. Open Forum Infectious Diseases, 2(3), Article ofv113. https://doi.org/10.1093/ofid/ofv113
- U.S. Food and Drug Administration. (2016, July 26). FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics
- The Joint Commission. (2019). R3 Report Issue 23: Antimicrobial stewardship in ambulatory health care. https://www.jointcommission.org/r3_report_23_antimicrobial_stewardship_in_ambulatory_health_care